Prevalence of Trismus in Patients With Maxillary Cancer With and Without Radiation Therapy in the Egyptian Population.
: Post-operative Prevalence of Trismus in Patients With Maxillary Cancer With and Without Radiation Therapy in the Egyptian Population.(a Cross Sectional Study)
1 other identifier
observational
360
1 country
1
Brief Summary
This study aims at evaluating the prevalence of trismus among maxillary cancer patients in the Egyptian population and the effect of radiotherapy on the occurrence of trismus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2021
CompletedFirst Posted
Study publicly available on registry
October 25, 2021
CompletedStudy Start
First participant enrolled
December 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedOctober 25, 2021
October 1, 2021
1 year
September 26, 2021
October 12, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
% prevalence
Trismus prevalence in percent
1 year
Secondary Outcomes (1)
MMO
1 year
Study Arms (2)
Radiotherapy (Yes or no) - Exercise (YES or NO)
with or without radiotherapy
MMO (in mm)
with or without radiotherapy
Interventions
patients who recieved radiotherapy after surgical removal of the tumor
Eligibility Criteria
patients with maxillary cancer attending faculty of dentistry ,CU and the national cancer institute.
You may qualify if:
- patients with maxillary cancer
You may not qualify if:
- patients under 18 yrs .
- patients with TMJ disorders before surgery
- patients on chemotherapy
- \- Tumors in other sites( Tongue , buccal mucosa , salivary glands, mandible)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Cairo University
Cairo, Haram, 12511, Egypt
Related Publications (1)
van der Geer SJ, van Rijn PV, Kamstra JI, Langendijk JA, van der Laan BFAM, Roodenburg JLN, Dijkstra PU. Prevalence and prediction of trismus in patients with head and neck cancer: A cross-sectional study. Head Neck. 2019 Jan;41(1):64-71. doi: 10.1002/hed.25369. Epub 2018 Dec 18.
PMID: 30561067RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Gamal Ashour
National Cancer Institute (NCI)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- : Post-operative Prevalence of trismus in patients with maxillary cancer with and without radiation therapy in the Egyptian population.(a cross sectional study)
Study Record Dates
First Submitted
September 26, 2021
First Posted
October 25, 2021
Study Start
December 1, 2021
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
October 25, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- 1-2 years
- Access Criteria
- Free access
the results of the study will be available at the college library for the researchers to benefit from.